Predict your next investment

HEALTHCARE | Medical Facilities & Services / Hospitals

See what CB Insights has to offer

Stage

Corporate Majority | Acquired

About Suchirayu HealthCare Solutions

Suchirayu HealthCare Solutions is a hospital operator in Hubli, India.On November 23rd, 2021, HealthCare Global Enterprises acquired a majority stake in Suchirayu HealthCare Solutions. Terms of the transaction were not disclosed.

Suchirayu HealthCare Solutions Headquarter Location

Hubli,

India

Latest Suchirayu HealthCare Solutions News

HealthCare Global Acquires Majority Stake In Suchirayu Healthcare

Nov 23, 2021

With the transaction, HCG has increased its holding in Suchirayu from the existing 17.7 per cent to 78.6 per cent, the company said in a statement. PTI November 22, 2021 / 11:26 AM IST The medicine is the first oral antiviral approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the treatment of mild-to-moderate COVID-19 in adults. (Representative image) Cancer focused healthcare service provider HealthCare Global Enterprises Limited (HCG) on Monday said it has become a majority stakeholder in Suchirayu Healthcare Solutions with the acquisition of additional 60.9 per cent for an undisclosed sum. With the transaction, HCG has increased its holding in Suchirayu from the existing 17.7 per cent to 78.6 per cent, the company said in a statement. Suchirayu owns a multi-speciality hospital in Hubli with an operational capacity of 110 beds and a potential to scale up to 250 beds. HCG has operated and maintained the hospital since August 2017 and had the right to increase its stake up to 80 per cent, the statement said. "Having operated Suchirayu for the past four years with successful patient outcomes and desired financial results, acquiring a majority was a logical step in cementing our presence in the region. We are confident that we will be able to derive multiple synergies with this acquisition," HCG Executive Chairman BS Ajaikumar said. HCG continues on its path to optimise capital allocations around cancer care and strengthen its pre-eminent position in the country, he added. HCG continues on its path to optimise capital allocations around cancer care and strengthen its pre-eminent position in the country, he added.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.